Literature DB >> 33604584

Safety and Efficacy of Cardiovascular Implantable Electronic Device Extraction in Elderly Patients: A Meta-Analysis and Systematic Review.

Andrew Y Lin1, Florentino Lupercio1, Gordon Ho1, Travis Pollema2, Victor Pretorius2, Ulrika Birgersdotter-Green1.   

Abstract

BACKGROUND: Transvenous lead extraction of cardiovascular implantable electronic device (CIED) has been proven safe in the general patient population with the advances in extraction techniques. Octogenarians present a unique challenge given their comorbidities and the perceived increase in morbidity and mortality.
OBJECTIVE: To assess the safety and outcomes of CIED extraction in octogenarians to younger patients.
METHODS: We performed an extensive literature search and systematic review of studies that compared CIED extraction in octogenarians versus non-octogenarians. We separately assessed the rate of complete procedure success, clinical success, procedural mortality, major and minor complications. Risk ratio (RR) 95% confidence intervals were measured using the Mantel-Haenszel method. The random effects model was used due to heterogeneity across study cohorts.
RESULTS: Seven studies with a total of 4,182 patients were included. There was no difference between octogenarians and non-octogenarians in complete procedure success (RR 1.01, 95% CI 1.00 - 1.02, p = 0.19) and clinical success (RR 1.01, 95% CI 1.00 - 1.01, p = 0.13). There was also no difference in procedural mortality (RR 1.43, 95% CI 0.46 - 4.39, p = 0.54), major complication (RR 1.40, 95% CI 0.68 - 2.88, p = 0.36), and minor complication (RR 1.43, 95% CI 0.90 - 2.29, p = 0.13).
CONCLUSION: In this study, there was no evidence to suggest a difference in procedural success and complication rates between octogenarians and younger patients. Transvenous lead extraction can be performed safely and effectively in the elderly population.

Entities:  

Keywords:  cardiovascular implantable electronic device; implantable cardioverter-defibrillator; octogenarian; pacemaker; transvenous lead extraction

Year:  2020        PMID: 33604584      PMCID: PMC7889020          DOI: 10.1016/j.hroo.2020.07.005

Source DB:  PubMed          Journal:  Heart Rhythm O2        ISSN: 2666-5018


The rates of complete procedural success and clinical success were similar between octogenarians and younger patients. Procedural mortality was low in both octogenarians and younger patients. There was no statistically significant difference between the 2 groups. There was no statistically significant difference in major and minor complications between the octogenarians and younger patients.

Introduction

The use of cardiovascular implantable electronic devices (CIED) such as implantable cardioverter-defibrillators (ICD), permanent pacemakers, and cardiac resynchronization therapy has become increasingly prevalent as an important aspect in the management of chronic heart disease. Inevitably, the increase in CIED implantation has paralleled the rise in need for CIED extraction, driven mainly by systems failure or device infection. Historically, the perceived risk of complications and lack of specialists has limited the performance of lead extractions. However, with growing physician experience and the improvement of extraction techniques,2, 3, 4 CIED extraction is now considered a relatively safe procedure. Prior studies have reported major complication rates of 0.7%–1.9% and minor complication rates of 1.4%–7.2% to be associated with transvenous CIED extraction.2, 3, 4,, A unique population worth separate consideration is the octogenarians. Given their higher number of comorbidities and likely longer duration of device implantation, CIED extraction may be delayed in favor of conservative treatment owing to the perceived risk of procedural morbidity and mortality. The issue of CIED extraction in octogenarians is of particular concern given the growing number of elderly patients living with CIEDs., While some studies have reported old age as a risk factor for worse outcomes in lead extraction, others have shown varying results.11, 12, 13, 14, 15, 16, 17 The purpose of our current study was to perform a systematic review of literature and meta-analysis to assess the safety and success rate of CIED extraction in octogenarians compared to younger patients.

Methods

Literature search

We performed a systematic review of PubMed, Medline, Google scholar, and the Cochrane Library. This was assessed up to January 2020. Restriction to humans was applied. The reference list of all eligible studies was also reviewed. Search terms included (octogenarian or elderly) and (implantable cardioverter-defibrillator or pacemaker or cardiovascular implantable electronic device) and extraction.

Study selection

Studies were selected by 2 independent reviewers. The PRISMA statement for reporting systemic reviews and meta-analyses was applied to the methods for this study. The studies had to fulfill the following criteria to be considered in the analysis: (1) Studies must have reported the safety and efficacy of CIED extraction in an elderly patient group vs a younger control group. (2) Elderly patient group must have a mean age of 80 years or greater. (3) Definition for lead extraction must be consistent with the Heart Rhythm Society expert consensus document. (4) Studies must have been published in a peer-reviewed scientific journal.

Study outcomes

We aimed to compare the rates of complete procedure success, clinical success, procedural mortality, and major and minor complications between the octogenarian and the nonoctogenarian groups. Term definitions were taken from the Heart Rhythm Society expert consensus document.

Data extraction

Two authors (A.L. and F.L.) independently performed the literature search and extracted data from eligible studies. Outcomes were extracted from original manuscripts. Information was gathered using standardized protocol and reporting forms. Discrepancies were resolved by consensus. Two reviewers (A.L. and F.L.) independently assessed the quality items and differences were resolved by consensus.

Individual study quality appraisal

Two authors (A.L. and F.L.) independently assessed the quality and reporting of the studies with the Newcastle-Ottawa scale. Three categories were included in the analysis. Study quality was then classified into 1 of 3 categories: (1) high quality (7–9 points), (2) satisfactory quality (4–6 points), or (3) unsatisfactory quality (0–3 points).

Statistical analysis

Data were summarized across comparison arms using the Mantel-Haenszel risk ratio (RR). Random-effects models for analyses were used owing to heterogeneity across study cohorts. Funnel plot analysis was used to address publication bias. Statistical analysis was performed using Review Manager (RevMan) Version 5.3 (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014. Continuous variables are presented as means with standard deviations (SD) and categorical or dichotomous variables are presented as numbers with percentage (%).

Results

Study selection and patient characteristics

The initial search resulted in 2188 abstracts, of which 1312 were duplications and 864 were excluded based on titles and abstracts (Figure 1). We included 7 studies in our final analysis with a total of 4182 patients (17% octogenarians). Baseline characteristics are summarized in Table 1. Patients were mostly male with multiple medical comorbidities. More octogenarians underwent lead extraction for the indication of infection than nonoctogenarians (71% vs 56%, P < .01), and octogenarians had a lower proportion of ICDs extracted relative to other types of CIEDs (19% vs 44%, P < .01). Study characteristics are shown in Table 2. All 7 studies were retrospective in nature; 6 were single-center studies. Year of CIED extraction ranged from 2001 to 2018.
Figure 1

Selection of studies.

Table 1

Patient demographics and characteristics

StudyRodriguez et al
Williams et al
Pelargonio et al
Kempa et al
Kutarski et al
El-Chami et al
Yagishita et al
OldYoungOldYoungOldYoungOldYoungOldYoungOldYoungOldYoung
Patients1183887233415069926134192106010067451184
Age, y85±464±1284±362±1484±361±1084±360±1483±363±1385±460±1586±567±15
Male78 (66)301 (78)53 (74)258 (77)96 (64)556 (80)16 (62)97 (72)105 (55)669 (63)63 (63)446 (66)34 (68)133 (73)
Lead age, mo60±5339±447174422955407684716711088
EF42±1735±1942±1445±1349±1342±1444±1040±15NRNR43±1536±1757±1554±16
Device type
 PPM68 (56)141 (36)46 (64)172 (51)126 (84)385 (55)24 (92)67 (50)147 (77)593 (56)36 (36)70 (10)42 (82)93 (51)
 ICD35 (28)181 (47)11 (15)96 (29)24 (16)314 (45)2 (8)63 (47)14 (7)305 (29)48 (48)496 (74)3 (6)63 (34)
 CRT-P2 (3)1 (1)1 (1)20 (6)Bi-V:Bi-V:Bi-V:Bi-V:Bi-V:Bi-V:Bi-VBi-V:3 (6)4 (2)
 CRT-D13 (13)65 (16)14 (19)46 (14)381700 (0)4 (3)31 (16)162 (15)16 (16)108 (16)3 (6)24 (13)
Indications
 Infection99 (84)296 (76)58 (80)207 (62)133 (89)573 (82)15 (58)64 (48)102 (53)448 (42)47 (47)225 (33)50 (98)116 (63)
 Lead failure17 (14)84 (21)9 (13)96 (29)NRNR6 (23)56 (42)NRNR39 (39)339 (50)1 (2)49 (27)
 Device upgradeNRNRNRNRNRNRNRNRNRNR7 (7)64 (10)0 (0)9 (5)
 SVC syndromeNRNR1 (1)3 (1)NRNR0 (0)2 (1)NRNRNRNR0 (0)2 (1)
 Chronic painNRNRNRNRNRNRNRNRNRNRNRNR0 (0)2 (1)
 OtherNRNR4 (6)28 (8)NRNR5 (19)12 (9)NRNR7 (7)46 (7)0 (0)6 (3)
Comorbidities
 HTN104 (88)324 (84)25 (41)89 (30)122 (81)502 (72)16 (62)61 (46)NRNR77 (77)411 (61)27 (53)70 (38)
 DM45 (38)190 (49)6 (10)30 (10)60 (40)222 (32)11 (42)37 (28)NRNR19 (19)206 (31)13 (26)40 (22)
 CAD72 (61)261 (67)35 (57)117 (38)41 (27)264 (38)12 (47)60 (45)NRNR50 (50)265 (39)10 (20)31 (17)
 CKD26 (22)84 (22)12 (18)44 (14)83 (55)182 (26)4 (15)21 (16)NRNR25 (25)131 (19)3 (6)7 (4)
 CVANRNR8 (13)18 (6)NRNRNRNRNRNRNRNRNRNR
 COPDNRNR7 (12)28 (9)69 (46)133 (19)NRNRNRNRNRNRNRNR

Values presented as mean ± standard deviation for continuous variables and number (percentage) for categorical variables.

Bi-V = biventricular; CAD = coronary artery disease; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; CRT-D = cardiac resynchronization therapy defibrillator; CRT-P = cardiac resynchronization therapy pacemaker; CVA = cerebrovascular accident; DM = diabetes mellitus; EF = ejection fraction; HTN = hypertension; ICD = implantable cardioverter-defibrillator; NR = not reported; PPM = permanent pacemaker; SVC = superior vena cava.

Table 2

Study characteristics

StudyRodriguez et alWilliams et alPelargonio et alKempa et alKutarski et alEl-Chami et alYagishita et al
Study designRetrospectiveRetrospectiveRetrospectiveRetrospectiveRetrospectiveRetrospectiveRetrospective
Years of extraction2004–20092001–20112005–20112003–20112006–20132007–20162013–2018
Year of publication2011201220122012201320172019
Study siteSingle centerSingle centerMulticenterSingle centerSingle centerSingle centerSingle center
Single operatorYesNoNoNot reportedYesNoNot reported
Follow-up30 daysAt least 30 daysNot reportedNot reportedNot reported3 yearsNot reported
Selection of studies. Patient demographics and characteristics Values presented as mean ± standard deviation for continuous variables and number (percentage) for categorical variables. Bi-V = biventricular; CAD = coronary artery disease; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; CRT-D = cardiac resynchronization therapy defibrillator; CRT-P = cardiac resynchronization therapy pacemaker; CVA = cerebrovascular accident; DM = diabetes mellitus; EF = ejection fraction; HTN = hypertension; ICD = implantable cardioverter-defibrillator; NR = not reported; PPM = permanent pacemaker; SVC = superior vena cava. Study characteristics

Study endpoints

There was no difference in complete procedural success (RR 1.01, 95% confidence interval [CI] 1.00–1.02, P = .19) and clinical success (RR 1.01, 95% CI 1.00–1.01, P = .13) between octogenarians and nonoctogenarians (Figure 2). There was also no statistically significant difference in procedural mortality (RR 1.43, 95% CI 0.46–4.39, P = .54), major complications (RR 1.40, 95% CI 0.68–2.88, P = .36), and minor complications (RR 1.43, 95% CI 0.90–2.29, P = .13) (Figures 3 and 4). Thirty-day mortality was comparable between the 2 groups (RR 1.14, 95% CI 0.41–3.15, P = .80).
Figure 2

Forest plot and funnel plot of efficacy outcomes of cardiovascular implantable electronic device extraction in octogenarians vs younger patients. A: Complete procedural success. B: Clinical success.

Figure 3

Comparative analysis of A: clinical success, B: major complication, and C: minor complication of device extraction in octogenarians vs younger control group.

Figure 4

Forest plot and funnel plot of safety outcomes of cardiovascular implantable electronic device extraction in octogenarians vs younger patients. A: Procedural mortality. B: Major complication. C: Minor complication.

Forest plot and funnel plot of efficacy outcomes of cardiovascular implantable electronic device extraction in octogenarians vs younger patients. A: Complete procedural success. B: Clinical success. Comparative analysis of A: clinical success, B: major complication, and C: minor complication of device extraction in octogenarians vs younger control group. Forest plot and funnel plot of safety outcomes of cardiovascular implantable electronic device extraction in octogenarians vs younger patients. A: Procedural mortality. B: Major complication. C: Minor complication.

Procedural characteristics

Procedural characteristics are summarized in Table 3. More than 7000 leads were extracted in the included studies. Most lead extractions were performed via the subclavian approach using manual traction or laser sheaths. Two studies reported no difference in procedure time between octogenarians and younger patients.
Table 3

Procedural characteristics

StudyRodriguez et al
Williams et al
Pelargonio et al
Kempa et al
Kutarski et al
El-Chami et al
Yagishita et al
OldYoungOldYoungOldYoungOldYoungOldYoungOldYoungOldYoung
Patients, n1183887233415069926134192106010067451184
Procedure timeNRNR88±5392±52NRNRNRNR104±46111±48NRNRNRNR
Technique
 MT0 (0)0 (0)35 (49)168 (50)26 (17)109 (15)NRNRNRNR42 (42)277 (41)0 (0)0 (0)
 LS118 (100)388 (100)37 (51)166 50)124 (83)578 (83)NRNRNRNR41 (41)304 (45)44 (86)165 (90)
 MS0 (0)0 (0)0 (0)0 (0 00 (0)12 (2)NRNRNRNR17 (17)93 (14)7 (14)19 (10)
Leads extracted
 Total25381414165730114103518521371078170NRNR
 Atrial99 (39)295 (36)57 (40)254 (39)97 (32)484 (34)12 (34)65 (35)914 (43)NRNRNRNR
 Ventricular145 (57)442 (54)70 (50)344 (52)166 (55)753 (53)23 (66)116 (63)1145 (54)NRNRNRNR
 CS9 (4)77 (10)14 (10)59 (9)38 (13)173 (13)0 (0)4 (2)78 (3)NRNRNRNR
Approach
 Subclavian116 (98)379 (98)70 (97)331 (97)NRNR25 (96)131 (98)NRNR96 (96)640 (95)NRNR
 Femoral2 (2)9 (2)2 (3)11 (3)NRNR1 (4)3 (2)NRNR4 (4)34 (5)NRNR

Values presented as mean ± standard deviation for continuous variables and number (percentage) for categorical variables.

CS = coronary sinus; LS = laser sheath; MS = mechanical sheath; MT = manual traction; NR = not reported.

Procedural characteristics Values presented as mean ± standard deviation for continuous variables and number (percentage) for categorical variables. CS = coronary sinus; LS = laser sheath; MS = mechanical sheath; MT = manual traction; NR = not reported.

Quality assessment and publication bias

Based on the Newcastle-Ottawa scale, 5 of the 7 studies were of high quality, 2 were satisfactory quality, and none were unsatisfactory quality (Table 4). Funnel plots did not reveal publication bias for any of the reported outcomes (Figures 2 and 4).
Table 4

Newcastle-Ottawa scale of the included studies

StudySelectionComparabilityOutcome§
Rodriguez et al312
Williams et al313
Pelargonio et al313
Kempa et al312
Kutarski et al323
El-Chami et al313
Yagishita et al313

Maximum 4 stars.

Maximum 2 stars.

Maximum 3 stars.

Newcastle-Ottawa scale of the included studies Maximum 4 stars. Maximum 2 stars. Maximum 3 stars.

Discussion

To the best of our knowledge, this is the first meta-analysis and systematic review of studies that have compared the safety and clinical outcomes of CIED extraction in octogenarians vs younger patients. The results of this meta-analysis show similar rates of clinical success and complete procedural success in elderly patients without an increase in procedural death or in major or minor complications. The proportion of elderly adults in the United States is rising and they account for a large portion of health care consumers, with an estimated annual increase of 5.4%–7.2%. More than 70% of pacemakers implanted in the United States are in patients aged >70 years, and up to two-thirds of ICDs are implanted in patients aged >65 years. Other large registries have shown 12%–20% of ICD implantations are in patients aged >80 years., The aging of patients living with CIED is a global phenomenon, as similar findings have been described in areas outside the United States, including Canada, Italy, and Korea. It is therefore important to expand the literature on the safety and efficacy of CIED extraction in elderly patients. A survey of 38 high-volume medical centers in Europe showed increasing age as a factor for hesitancy of clinicians in proceeding with lead extraction, likely owing to higher perceived risk for adverse events. Since then, several studies have evaluated age as a predictor of perioperative complications in transvenous lead extractions. In a multicenter study using data from the National Cardiovascular Data Registry Implantable Cardioverter-Defibrillator Registry involving 11,304 extraction procedures, age was not found to be associated with major complications on univariate analysis, with an odds ratio of 1.00. In a separate registry study involving 91,890 transvenous lead extractions, more elderly patients experienced procedural complications, but the results were not statistically significant when adjusted with multivariate analysis. Contrary to the above, Maytin and colleagues reported increasing age at time of lead extraction as a correlate with increased mortality risk. Similarly, a meta-analysis involving 62 studies suggested increasing age as a risk factor for major complications or death in patients who undergo laser lead extraction. The ambiguity in literature on safety of lead extractions in elderly patients may be due to the overall low complication rate, making accurate risk analysis difficult. One of the concerns for increased periprocedural complications for octogenarians arises from the assumption that older patients are frailer and have more comorbidities. However, it is important to note that this was not consistently observed in the studies included in this meta-analysis. In a study by Rodriguez and colleagues, the majority of patients had 3 or more comorbidities but there was no statistically significant difference between the octogenarians and the younger cohort. In a separate study by Williams and colleagues, octogenarians had more comorbidities than nonoctogenarians but only the difference in ischemic heart disease was statistically significant when the prevalence of each comorbidity is compared individually. In other studies, octogenarians actually had lower prevalence of coronary artery disease and diabetes, and higher ejection fraction, compared to nonoctogenarians., This finding may be attributed to the fact that older patients with higher numbers of comorbidities may not receive CIED implantation in the first place. Although previous landmark trials have shown decreased mortality with ICD and cardiac resynchronization therapy in certain patient populations, this benefit is less well defined in octogenarians, given their lower ratio of arrhythmic to nonarrhythmic deaths. Prior works have reported 30-day mortality in patients undergoing lead extraction to be 2%–3%., However, this was not more commonly observed in octogenarians based on this current meta-analysis. One of the included studies assessed mortality up to 3 years after lead extraction between octogenarians and the younger cohort. Although there was a slight divergence of Kaplan-Meier survival curve after 1.5 years favoring younger patients, this was not statistically significant (P = .203). This finding suggests long-term outcomes of lead extraction in octogenarians are excellent and comparable to younger patients. Notably, more patients in the octogenarian group underwent lead extraction for the indication of CIED infection compared to the nonoctogenarian group. This is consistent with clinical practice, as the decision to proceed with CIED extraction is a result of shared decision-making considering the risks vs potential benefits of the procedure. Although extraction of an infected CIED is a class I indication, other common indications listed in the included studies (ie, lead failure, device upgrade) are more often performed in younger patients, as they are expected to live long enough to derive the long-term benefits. Although this may introduce selection bias, in the context that extraction of infected CIEDs has previously been associated with an increased risk for procedural complications,, octogenarians did not experience more adverse outcomes despite having more infected lead extractions. Another notable difference is the lower proportion of defibrillating leads extracted in octogenarians, which can be more difficult to extract and may be associated with a higher risk of adverse outcomes. The current meta-analysis has several limitations that should be acknowledged. First, most of the studies included were single-center experiences and, in some cases, single-operator outcomes, which limits the generalizability of our findings. This is especially important, as procedural success has been associated with proceduralist experience. Next, there was notable heterogeneity on lead characteristics and indications for extraction in the studies. Multiple risk factors reported in literature to be associated with increased complications were not addressed in this study, as the lack of data available precludes the performance of sensitivity analysis. Third, all included studies were retrospective and our findings are limited by the nature of retrospective designs.

Conclusion

In patients undergoing CIED extraction, there is no evidence to suggest a difference in procedural success and complication rates between octogenarians and younger patients. Based on our meta-analysis, clinicians may consider CIED extraction in elderly patients as a safe and effective management option.

Funding Sources

This research was partially funded by the , AHA 19CDA34760021) and , NIH 1KL2TR001444) to GH.

Disclosures

Dr Ho receives grant support from the American Heart Association (AHA 19CDA34760021) and National Institutes of Health (NIH 1KL2TR001444). He also reports equity in Vektor Medical Inc unrelated to this work. Dr Birgersdotter-Green has received grant support from Abbott Laboratories and honoraria from Medtronic, Abbott, and Boston Scientific. The rest of the authors have no conflicts of interest.
  34 in total

1.  Clinical study of the laser sheath for lead extraction: the total experience in the United States.

Authors:  Charles L Byrd; Bruce L Wilkoff; Charles J Love; T Duncan Sellers; Christopher Reiser
Journal:  Pacing Clin Electrophysiol       Date:  2002-05       Impact factor: 1.976

2.  Trends in Use and Adverse Outcomes Associated with Transvenous Lead Removal in the United States.

Authors:  Abhishek Deshmukh; Nileshkumar Patel; Peter A Noseworthy; Achint A Patel; Nilay Patel; Shilpkumar Arora; Suraj Kapa; Amit Noheria; Siva Mulpuru; Apurva Badheka; Avi Fischer; James O Coffey; Yong Mei Cha; Paul Friedman; Samuel Asirvatham; Juan F Viles-Gonzalez
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

3.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

4.  Long-term mortality after transvenous lead extraction.

Authors:  Melanie Maytin; Samuel O Jones; Laurence M Epstein
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-02-23

5.  Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experience.

Authors:  Sebastiaan Deckx; Thomas Marynissen; Filip Rega; Joris Ector; Dieter Nuyens; Hein Heidbuchel; Rik Willems
Journal:  Europace       Date:  2014-02-25       Impact factor: 5.214

Review 6.  2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.

Authors:  Fred M Kusumoto; Mark H Schoenfeld; Bruce L Wilkoff; Charles I Berul; Ulrika M Birgersdotter-Green; Roger Carrillo; Yong-Mei Cha; Jude Clancy; Jean-Claude Deharo; Kenneth A Ellenbogen; Derek Exner; Ayman A Hussein; Charles Kennergren; Andrew Krahn; Richard Lee; Charles J Love; Ruth A Madden; Hector Alfredo Mazzetti; JoEllyn Carol Moore; Jeffrey Parsonnet; Kristen K Patton; Marc A Rozner; Kimberly A Selzman; Morio Shoda; Komandoor Srivathsan; Neil F Strathmore; Charles D Swerdlow; Christine Tompkins; Oussama Wazni
Journal:  Heart Rhythm       Date:  2017-09-15       Impact factor: 6.343

7.  Transvenous excimer laser-assisted lead extraction of cardiac implantable electrical devices in the Japanese elderly population.

Authors:  Atsuhiko Yagishita; Masahiko Goya; Masahiro Sekigawa; Tasuku Yamamoto; Kikou Akiyoshi; Shingo Maeda; Yoshihide Takahashi; Mihoko Kawabata; Kenzo Hirao
Journal:  J Cardiol       Date:  2019-10-10       Impact factor: 3.159

8.  Procedural outcomes and long-term survival following lead extraction in octogenarians.

Authors:  Mikhael F El-Chami; Michael N Sayegh; Adarsh Patel; Jad El-Khalil; Yaanik Desai; Angel R Leon; Faisal M Merchant
Journal:  Pacing Clin Electrophysiol       Date:  2017-06-16       Impact factor: 1.976

9.  Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006.

Authors:  Steven M Kurtz; Jorge A Ochoa; Edmund Lau; Yakov Shkolnikov; Behzad B Pavri; Daniel Frisch; Arnold J Greenspon
Journal:  Pacing Clin Electrophysiol       Date:  2010-01-04       Impact factor: 1.976

10.  Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry.

Authors:  Nitesh Sood; David T Martin; Rachel Lampert; Jeptha P Curtis; Craig Parzynski; Jude Clancy
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.